Tumor cell lipid membrane

The tumor cell lipid membrane is a specialized phospholipid bilayer that serves as the primary interface between a malignant cell and its microenvironment. It is characterized by significant biochemical alterations compared to healthy cells, most notably the loss of lipid asymmetry which results in the exposure of negatively charged phosphatidylserine on the outer leaflet (Papo & Shai, 2005, Cancer Research). These changes, along with altered cholesterol levels and increased membrane fluidity, create a unique biophysical profile that supports oncogenic signaling and protects the cell from apoptosis. Therapeutic strategies targeting this structure leverage these differences to achieve selectivity, using cationic anticancer peptides or alkylphospholipids to induce membrane permeabilization or disrupt lipid rafts (van Blitterswijk & Verheij, 2013, Biochimica et Biophysica Acta). By directly targeting the physical integrity of the membrane, these agents can bypass traditional intracellular resistance mechanisms, making the tumor membrane a critical target for novel oncology drug development.

Other names

Cancer cell membraneTumor plasma membraneNeoplastic cell membraneMalignant cell membrane

Drugs targeting the tumor cell lipid membrane typically act by disrupting the structural integrity of the bilayer through pore formation (toroidal or barrel-stave models), detergent-like micellization, or by modulating lipid raft-associated signaling pathways. Many agents exploit the increased electronegativity of the tumor surface—caused by phosphatidylserine externalization—to achieve selective binding and subsequent lysis or induction of apoptosis (Riedl et al., 2011, Chemistry and Physics of Lipids).